Nile Pharma records EGP 44.1M profit in 5 months

Updated 12/26/2021 12:47:03 PM

ArabFinance: The board of directors of El Nile Company for Pharmaceuticals and Chemical Industries (Nile Pharma) (NIPH) has approved the financial indicators for the period from July until November 2021, according to a statement filed to the Egyptian Exchange (EGX).

The financial indicators showed that the company has recorded a net profit before tax of EGP 44.10 million in the July-November period of 2021, compared to a profit of EGP 45.3 million in the year-ago period.

It is worth noting that the company’s net profit after tax fell to EGP 18.71 million in the first quarter of fiscal year (FY) 2021/2022 from EGP 22.29 million in the year-ago period.

Nile Pharma manufactures and markets pharmaceuticals, various types of medical materials, chemical products, and cosmetics, as well as surgical threads and medical solutions.